FDA Peptide Category 2 Removal & Public Meeting July 23rd Mansi Hukmani posted on the topic LinkedIn FDA Removes 12 Peptides from 503A Category 2 : r us_pharmacies RFK Jr. & claimed regenerative peptides like BPC 157 The Niche Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # FDA considers adding a dozen peptides to its bulk drug compounding list RAPS